Indication
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Elocta can be used for all age groups.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Elocta 1000 UI polvo y disolvente para solucion inyectableSpain · 133,3 µgMarketed
- Elocta 1500 UI polvo y disolvente para solucion inyectableSpain · 200 µgMarketed
- Elocta 2000 UI polvo y disolvente para solucion inyectableSpain · 266,7 µgMarketed
- Elocta 250 UI polvo y disolvente para solucion inyectableSpain · 33,3 µgMarketed